IMT1
IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1 reduces deoxynucleoside triphosphate levels and citric acid cycle intermediates, resulting in a marked depletion of cellular amino acid levels. IMT1 has the potential for mitochondrial transcription disorders related diseases[1].
Product Specifications
CAS Number
[2304621-31-4]
UNSPSC
12352005
Target
DNA/RNA Synthesis; Mitochondrial Metabolism; Oxidative Phosphorylation
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/imt1.html
Concentration
10mM
Purity
99.86
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC(OC1=CC=C(C(O2)=C1)C(C3=CC=CC=C3C)=CC2=O)C(N(C)C)=O
Molecular Formula
C21H21NO4
Molecular Weight
351.40
References & Citations
[1]Nina A Bonekamp, et al. Small-molecule inhibitors of human mitochondrial DNA transcription. Nature. 2020 Dec;588 (7839) :712-716.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![1-Benzenesulfonyl-5-fluoro-3-iodo-1h-pyrrolo[2,3-b]pyridine](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
